Payment overview · 2025
General Payments
$95.87
1 reported records · 1 companies
Healthcare provider profile · identity verified
Kevin O'Brien, MD
Allopathic & Osteopathic Physicians|Family Medicine · ROCHESTER, IN · NPI 1003867771
Verified facts
What the public records show
CMS Open Payments records show Kevin O'Brien, MD received $95.87 in general payments during 2025 across 1 reported records.
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $95.87 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $95.87 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $95.87 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 577 | 168 |
| Losartan Potassium | Losartan Potassium | 543 | 150 |
| Levothyroxine Sodium | Levothyroxine Sodium | 468 | 128 |
| Metoprolol Succinate | Metoprolol Succinate | 374 | 108 |
| Omeprazole | Omeprazole | 348 | 114 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 321 | 85 |
| Metformin Hcl | Metformin Hcl | 318 | 97 |
| Amlodipine Besylate | Amlodipine Besylate | 311 | 93 |
| Gabapentin | Gabapentin | 306 | 91 |
| Tamsulosin Hcl | Tamsulosin Hcl | 267 | 80 |
| Montelukast Sodium | Montelukast Sodium | 250 | 76 |
| Lisinopril | Lisinopril | 246 | 71 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 242 | 112 |
| Famotidine | Famotidine | 234 | 80 |
| Azithromycin | Azithromycin | 231 | 175 |
| Furosemide | Furosemide | 230 | 76 |
| Eliquis | Apixaban | 229 | 52 |
| Allopurinol | Allopurinol | 197 | 56 |
| Duloxetine Hcl | Duloxetine Hcl | 195 | 58 |
| Prednisone | Prednisone | 191 | 113 |
| Clopidogrel | Clopidogrel Bisulfate | 181 | 54 |
| Simvastatin | Simvastatin | 175 | 52 |
| Carvedilol | Carvedilol | 171 | 58 |
| Pantoprazole Sodium | Pantoprazole Sodium | 158 | 47 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 153 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 148 | 40 |
| Tramadol Hcl | Tramadol Hcl | 147 | 34 |
| Trazodone Hcl | Trazodone Hcl | 147 | 43 |
| Cephalexin | Cephalexin | 136 | 94 |
| Ozempic | Semaglutide | 136 | 30 |
| Jardiance | Empagliflozin | 135 | 39 |
| Alprazolam | Alprazolam | 132 | 28 |
| Meloxicam | Meloxicam | 128 | 42 |
| Potassium Chloride | Potassium Chloride | 128 | 32 |
| Spironolactone | Spironolactone | 127 | 41 |
| Glimepiride | Glimepiride | 115 | 38 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 115 | 39 |
| Atenolol | Atenolol | 109 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 106 | 32 |
| Cefuroxime | Cefuroxime Axetil | 96 | 84 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 94 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 92 | 26 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 91 | 30 |
| Sertraline Hcl | Sertraline Hcl | 82 | 24 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 78 | 23 |
| Methylprednisolone | Methylprednisolone | 75 | 67 |
| Lorazepam | Lorazepam | 74 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 74 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 70 | 52 |
| Labetalol Hcl | Labetalol Hcl | 70 | 19 |
| Ondansetron Odt | Ondansetron | 69 | 32 |
| Ventolin Hfa | Albuterol Sulfate | 69 | 18 |
| Warfarin Sodium | Warfarin Sodium | 68 | 19 |
| Meclizine Hcl | Meclizine Hcl | 66 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 63 | 24 |
| Alendronate Sodium | Alendronate Sodium | 60 | 13 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 60 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 58 | 28 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 58 | 48 |
| Lovastatin | Lovastatin | 55 | 15 |
| Hydrochlorothiazide | Hydrochlorothiazide | 53 | 23 |
| Finasteride | Finasteride | 50 | 18 |
| Hydrocortisone | Hydrocortisone | 50 | 12 |
| Ketoconazole | Ketoconazole | 50 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 48 | 11 |
| Clonidine Hcl | Clonidine Hcl | 47 | 13 |
| Mounjaro | Tirzepatide | 47 | suppressed |
| Pregabalin | Pregabalin | 47 | suppressed |
| Januvia | Sitagliptin Phosphate | 46 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 46 | 14 |
| Symbicort | Budesonide/Formoterol Fumarate | 45 | 18 |
| Mirtazapine | Mirtazapine | 44 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 43 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 43 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 42 | 12 |
| Fluconazole | Fluconazole | 42 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 42 | 14 |
| Levofloxacin | Levofloxacin | 41 | 31 |
| Nifedipine Er | Nifedipine | 41 | 14 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 40 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | 11 |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 39 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 39 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 38 | 11 |
| Celecoxib | Celecoxib | 38 | 11 |
| Acyclovir | Acyclovir | 37 | 20 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | 12 |
| Xarelto | Rivaroxaban | 37 | 11 |
| Irbesartan | Irbesartan | 36 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 36 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 34 | 11 |
| Valsartan | Valsartan | 34 | suppressed |
| Amoxicillin | Amoxicillin | 33 | 30 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 33 | 26 |
| Ezetimibe | Ezetimibe | 33 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 33 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 33 | suppressed |
| Clonazepam | Clonazepam | 32 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 30 | 16 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 30 | suppressed |
| Diazepam | Diazepam | 30 | 12 |
| Glipizide | Glipizide | 30 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 29 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 29 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | suppressed |
| Lansoprazole | Lansoprazole | 28 | suppressed |
| Mupirocin | Mupirocin | 28 | 19 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 28 | 18 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 26 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 25 | suppressed |
| Bupropion Xl | Bupropion Hcl | 23 | suppressed |
| Estradiol | Estradiol | 23 | suppressed |
| Primidone | Primidone | 23 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 23 | suppressed |
| Levetiracetam | Levetiracetam | 22 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 20 | suppressed |
| Entresto | Sacubitril/Valsartan | 20 | suppressed |
| Nexletol | Bempedoic Acid | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Pentoxifylline | Pentoxifylline | 19 | suppressed |
| Rybelsus | Semaglutide | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 18 | suppressed |
| Bumetanide | Bumetanide | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 13 |
| Droplet Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | 16 |
| Clarithromycin | Clarithromycin | 17 | 14 |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Folic Acid | Folic Acid | 16 | suppressed |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 15 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 15 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 15 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Scopolamine | Scopolamine | 14 | suppressed |
| Trospium Chloride | Trospium Chloride | 14 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 13 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 12 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Cilostazol | Cilostazol | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $95.87 · 1 records | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error